Breztri Aerosphere 7.2 mcg (Glycopyrronium (Glycopyrronium Bromide) AEROSOL, METERED DOSE) 7.2 MCG

BREZTRI AEROSPHERE 7.2 MCG is a metered-dose aerosol containing glycopyrronium bromide, used for respiratory conditions. This inhalation medication helps manage symptoms like bronchospasms and improves breathing.

Strength

7.2 MCG

Manufacturer / TM Owner

ASTRAZENECA CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BREZTRI AEROSPHERE 7.2 MCG is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the airways, making it easier to breathe. This medication is often prescribed to individuals experiencing symptoms such as wheezing, shortness of breath, and coughing due to COPD. What is BREZTRI AEROSPHERE used for? It is designed to provide long-term relief and improve lung function in patients with this condition.

Side Effects

Common effects of BREZTRI AEROSPHERE 7.2 MCG may include dry mouth, throat irritation, and coughing immediately after inhalation. Some users might experience headaches or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare provider.

Precautions & Warnings

BREZTRI AEROSPHERE 7.2 MCG should be used with caution in patients with a history of hypersensitivity to glycopyrronium bromide or similar medications. It is important to follow the prescribed dosage and administration instructions carefully. Patients should avoid exposing the aerosol to extreme temperatures and store it in a cool, dry place.

Avoid Interactions

BREZTRI AEROSPHERE 7.2 MCG may interact with other medications, including beta-blockers and certain antihistamines. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

Frequently Asked Questions

BREZTRI AEROSPHERE 7.2 MCG is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve breathing and reduce symptoms like wheezing and shortness of breath.

BREZTRI AEROSPHERE 7.2 MCG is administered via inhalation using a metered-dose aerosol. Follow the instructions provided by your healthcare provider for proper use.

Common side effects may include dry mouth, throat irritation, coughing, headaches, and dizziness. These effects are usually mild and temporary.

BREZTRI AEROSPHERE 7.2 MCG may interact with other medications, so it is important to consult your healthcare provider before combining it with other treatments.

Store BREZTRI AEROSPHERE 7.2 MCG in a cool, dry place away from extreme temperatures and direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.